(Q46880557)
Statements
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection (English)
George Z Retsch-Bogart
Jane L Burns
Kelly L Otto
Karen McCoy
Christopher Oermann
Ronald L Gibson
AZLI Phase II Study Group